Eye Care (Pharmacies) - Central Asia

  • Central Asia
  • Revenue in the Eye Care market is projected to reach US$24.55m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.33%, resulting in a market volume of US$30.35m by 2029.
  • In global comparison, most revenue will be generated in Japan (US$904.40m in 2024).
  • In relation to total population figures, per person revenues of US$0.31 are generated in 2024.

Key regions: Canada, Europe, India, Australia, South Korea

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care (Pharmacies) market in Central Asia is developing rapidly due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Eye Care (Pharmacies) market in Central Asia are shifting towards a greater focus on preventive eye care and a growing demand for innovative and high-quality products. Customers are becoming more aware of the importance of maintaining good eye health and are seeking products that can help them achieve this goal. They are also becoming more conscious of the potential risks associated with prolonged screen time and are looking for solutions to protect their eyes from digital strain. Additionally, there is a growing demand for contact lenses and fashionable eyewear, driven by changing fashion trends and the desire to enhance personal style. Trends in the market include the increasing availability of online and e-commerce platforms, which provide customers with convenient access to a wide range of eye care products. This trend is particularly prevalent in urban areas, where consumers have greater access to the internet and are more comfortable making online purchases. The rise of online platforms has also led to increased competition among retailers, as they strive to offer competitive prices and attractive discounts to attract customers. Local special circumstances in Central Asia, such as a rapidly growing population and increasing urbanization, are contributing to the development of the Eye Care (Pharmacies) market. As more people move to urban areas, the demand for eye care products and services is expected to rise. Additionally, the prevalence of certain eye conditions, such as myopia and cataracts, is increasing due to factors such as genetics and lifestyle changes. This has created a greater need for eye care solutions and has driven the growth of the market. Underlying macroeconomic factors, such as rising disposable incomes and improving healthcare infrastructure, are also fueling the development of the Eye Care (Pharmacies) market in Central Asia. As people have more money to spend, they are willing to invest in their eye health and are more likely to purchase eye care products. Furthermore, improvements in healthcare infrastructure, including the availability of specialized eye care clinics and the training of healthcare professionals, have made eye care services more accessible to the general population. In conclusion, the Eye Care (Pharmacies) market in Central Asia is experiencing rapid growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As customers increasingly prioritize preventive eye care and seek innovative products, the market is responding by offering a wider range of options. The availability of online platforms and the growth of urban areas are also contributing to the market's development. With rising disposable incomes and improving healthcare infrastructure, the Eye Care (Pharmacies) market in Central Asia is expected to continue expanding in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)